Cancer cases are expected to more than double between the years 2000 and 2030, says the director of the World Health Organization's International Agency for Research on Cancer.

This upward climb will occur primarily in poor countries due to an increase in population growth, longer life expectancy, more smoking, and a lack of health care in low and medium-resource countries.

"What's going to happen between now and 2030 is that the population is going to increase from about 6.5 billion to 8 billion in 2030," Dr. Peter Boyle reports. "So even if the risks remain constant at each five-year age group, because we've got more people around, we're going to have more cases of cancer.

It's the unfortunate successes for developed countries over the past 40 years, such as the export of cigarette smoking and alcohol consumption, that have doomed poorer countries, says Boyle.

Consider this definition of doom: By the year 2030, there will be 27 million cases of cancer, 17 million deaths caused by the disease, and 75 million people living with cancer.

I guess the concept is happy -- the public urging for our world's policy makers to make cancer a top priority -- but the fact that becomes all too apparent on this World Cancer Day is quite sobering. More than seven million people die from cancer and close to 11 million new cases are diagnosed worldwide each year. In 2006, cancer killed more people than AIDS, malaria, and tuberculosis combined.

So today is both happy and sad. But for now, let's focus on the happy.

The Geneva-based International Union Against Cancer (UICC) and member organizations in 86 countries are launching a five-year campaign to impart life lessons to children so they can prevent cancer later in life. Parents are critical in this campaign and must take an active role in teaching their children techniques for saving their lives.

Forty-three percent of cancer cases can be prevented through healthy lifestyles that begin in childhood. The World Cancer Campaign slogan -- Today's Children, Tomorrow's World -- underscores the possibility that a concerted effort among world leaders, parents, and their children can make a real difference through four key actions -- providing a smoke-free environment for children; ensuring children keep physically active, eat a healthy diet, and avoid obesity; educating children about vaccines for virus-related liver and cervical cancers; and limiting children's exposure to the sun.

Former First Lady Barbara Bush, Her Royal Highness Lalla Slama of Morocco, Nigerian President Olusegun Obasanjo, and tennis star Steffi Graf are some of the powerful voices powering this campaign that UICC president Dr. Franco Cavalli says can save so many lives if embraced by those at the highest decision-making levels.

"Complacency and inaction on the part of world community will effectively contribute to more than 10 million deaths every year by 2020," he said.

United States drug company Merck hopes to offer the cervical cancer vaccine Gardasil to developing countries at much lower prices -- within months, if possible.

Currently, the three-dose vaccine is not affordable in the developing world -- where 80 percent of cervical cancer deaths occur and 95 percent of females have never had a Pap test . And while the exact discounted price has not yet been determined, Merck professionals report they are committed to slashing the price of Gardasil for these women.

Merck also aims to help developing countries receive drugs sooner. Right now, there is a time lag of 15 to 20 years between the approval of drugs in the West and the time they reach these countries.

The lung cancer drug Gefitinib has been taken off shelves in the United States due to ineffectiveness. But it remains effective in some Taiwanese lung cancer patients, according to a study published in the journal Lung Cancer.

The study, conducted by the National Health Research Institutes, involved 65 non-small-cell lung cancer patients and found that more than 50 percent of participants responded to the drug therapy -- while only 10 percent respond in Western studies.

A genetic mutation of the epidermal growth factor receptor (EGFR) was found in most patients who responded to Gefitinib. The mutation is rare in Western countries but much more common in East Asian countries where the mutation increases the likelihood of developing adenocarcinoma.

About 6,800 Taiwanese patients develop non-small-cell lung cancer every year. Of these, 65 percent of cases are adenocarcinoma. Of this group, 57 percent will have the genetic mutation. And roughly half will respond to Gefitinib.

It does not surprise me that the Cleveland Clinic Cancer Center is among the best in the nation -- with internationally recognized physicians -- because I have always known this hospital to be the one stop where all medical difficulties and mysteries might be best managed -- in Ohio anyway. Growing up just an hour away from this facility, I thought maybe this was just the best Ohio hospital and that people headed here when other area hospitals could not deliver the best care. But now I know that the Cleveland Clinic is a destination for people from many states and countries. U.S. News & World Reports names the Cleveland Clinic one of the nation's top three hospitals, the clinic's heart program is ranked number one, it boasts a highly successful Children's Hospital, and cancer patients travel from all over the world for leading-edge cancer care at the Cleveland Clinic Taussig Cancer Center. There is even a Cleveland Clinic location in Florida. This hospital -- that I once believed was nothing more than a local healing place -- has quite a reach. And quite a reputation.

I just received in the mail my Certificate of Completion for St. Jude's  Campaign for a Cure. I have never really known much about St. Jude Children's Research Hospital -- except that I can be brought to tears by the television specials that showcase sick children whose lives depend on the research and treatment that this hospital offers. But I came to know more about St. Jude this year after a friend asked me to make a donation for the Up 'til Dawn program he sponsors on the college campus where he works -- a program that involves more than 150 college campuses nationwide and partners faculty, staff, students, and communities in an extravaganza of activity, education, and fundraising to benefit the children at St. Jude. So I made a donation and then was contacted by St. Jude with an invitation to help them further -- and I did. I sent out 10 pre-written letters to friends and family asking for their support. I was given an attainable fundraising goal. And I met it. So this is why I received my certificate -- and some cheery address labels too.

It is official. The first cervical cancer vaccine has been approved by the Food and Drug Administration, FDA. Merck's Gardasil cervical cancer vaccine is the first of several cancer vaccines expected to win approval this year. Gardasil, which targets human papillomavirus, HPV, will be given in three doses over six months. HPV is known to be responsible for the majority of cervical cancer cases.

The cervical cancer vaccine is not without its warnings though. In an earlier post, cervical cancer vaccine protects and promotes cancer, we noted a caution that research has shown the vaccine can actually raise the risk of cervical cancer if the woman is already infected with HPV at the time she receives the cervical cancer vaccine. So, it is not for every woman.

We also noted in an earlier post, cancer vaccine facing Christian Right opposition, there is strong objection to the cervical cancer vaccine based on religious convictions regarding sex and teenage girls. According to experts, girls in their early teens are the most likely to benefit from the cervical cancer vaccine. 

The international health group PATH has received an infusion of cash from Microsoft's Bill Gates to support the launch of a program that will provide the new cervical cancer vaccines to women in poor countries. With a $27.8 million grant from the Bill & Melinda Gates Foundation, PATH will begin in India, Peru, Uganda and Vietnam. Of the 250,000 women who die from cervical cancer each year, most of them live in the world's poorest countries. 

The sexually-transmitted human papillomavirus, HPV, is believed to be responsible for nearly three-fourths of cervical cancer diagnosis. Two cervical cancer vaccines, Merck's Gardasil and GlaxoSmithKline's Cervarix, will become available this year to protect women from the virus. In previous posts, we wondered what would happen to women who live in poor countries and how the cancer vaccine would be made available for them. This sounds like a start.

The costs of medical care are skyrocketing. Governments are grappling with the rising costs in how to provide healthcare and cancer patients are struggling to get the care they need. Where is the unfolding national and global healthcare crisis headed and what will our healthcare look like in the future?

According to the World Bank, the healthcare gap between rich and poor countries remains steady and warns the trend is likely to continue without some type of fundamental change in how we care for people in less-prosperous countries. Jean-Louis Sarbib, vice president for the World Bank's division that produced the new report, is quoted as saying, "This inequity has tremendous consequences for the health of the world's poor." It is predicted that the world's population is expected to grow from 6 billion today to a projected 7.5 billion by 2020, with most of the growth expected to be in developing countries.